

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.95531476 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.95531476 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.80569257 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.80569257 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 5.80011612 |
| 6 | ethanol oxidation (GO:0006069) | 5.57387518 |
| 7 | cysteine metabolic process (GO:0006534) | 5.37349093 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.32698729 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.20514771 |
| 10 | flavonoid metabolic process (GO:0009812) | 4.94090096 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 4.79531536 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 4.79531536 |
| 13 | tryptophan catabolic process (GO:0006569) | 4.79531536 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 4.71693469 |
| 15 | lysine metabolic process (GO:0006553) | 4.64048076 |
| 16 | lysine catabolic process (GO:0006554) | 4.64048076 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.62263938 |
| 18 | homocysteine metabolic process (GO:0050667) | 4.61800721 |
| 19 | bile acid biosynthetic process (GO:0006699) | 4.59517563 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.55494058 |
| 21 | drug catabolic process (GO:0042737) | 4.55199996 |
| 22 | urea cycle (GO:0000050) | 4.55092991 |
| 23 | urea metabolic process (GO:0019627) | 4.55092991 |
| 24 | tryptophan metabolic process (GO:0006568) | 4.50815959 |
| 25 | ethanol metabolic process (GO:0006067) | 4.48673437 |
| 26 | xenobiotic catabolic process (GO:0042178) | 4.46926075 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46212644 |
| 28 | cellular ketone body metabolic process (GO:0046950) | 4.43100478 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.38853331 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 4.38135293 |
| 31 | exogenous drug catabolic process (GO:0042738) | 4.34911121 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.26576240 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.19835208 |
| 34 | cellular glucuronidation (GO:0052695) | 4.15817306 |
| 35 | short-chain fatty acid metabolic process (GO:0046459) | 4.08103115 |
| 36 | regulation of protein activation cascade (GO:2000257) | 4.06703291 |
| 37 | bile acid metabolic process (GO:0008206) | 4.05517705 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.04708016 |
| 39 | drug transmembrane transport (GO:0006855) | 4.04193938 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.02625365 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 4.01952355 |
| 42 | epoxygenase P450 pathway (GO:0019373) | 4.01774400 |
| 43 | surfactant homeostasis (GO:0043129) | 4.00615230 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.96594445 |
| 45 | protein carboxylation (GO:0018214) | 3.96594445 |
| 46 | drug metabolic process (GO:0017144) | 3.94820285 |
| 47 | bile acid and bile salt transport (GO:0015721) | 3.93731712 |
| 48 | NADH metabolic process (GO:0006734) | 3.93102644 |
| 49 | response to nitrosative stress (GO:0051409) | 3.87292741 |
| 50 | regulation of complement activation (GO:0030449) | 3.86736794 |
| 51 | fatty acid oxidation (GO:0019395) | 3.85674095 |
| 52 | ketone body metabolic process (GO:1902224) | 3.85635105 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 3.85588625 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 3.83746007 |
| 55 | glucuronate metabolic process (GO:0019585) | 3.82686515 |
| 56 | uronic acid metabolic process (GO:0006063) | 3.82686515 |
| 57 | primary alcohol catabolic process (GO:0034310) | 3.82361820 |
| 58 | benzene-containing compound metabolic process (GO:0042537) | 3.80225119 |
| 59 | lipid oxidation (GO:0034440) | 3.78082388 |
| 60 | fatty acid beta-oxidation (GO:0006635) | 3.77595071 |
| 61 | alpha-amino acid catabolic process (GO:1901606) | 3.77048893 |
| 62 | negative regulation of sterol transport (GO:0032372) | 3.75162950 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 3.75162950 |
| 64 | carnitine metabolic process (GO:0009437) | 3.73869880 |
| 65 | iron ion import (GO:0097286) | 3.71047875 |
| 66 | urate metabolic process (GO:0046415) | 3.69704081 |
| 67 | response to mercury ion (GO:0046689) | 3.68561375 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.66789561 |
| 69 | tyrosine metabolic process (GO:0006570) | 3.63382039 |
| 70 | aldehyde catabolic process (GO:0046185) | 3.61134732 |
| 71 | desmosome organization (GO:0002934) | 3.59136917 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 3.59121875 |
| 73 | regulation of plasminogen activation (GO:0010755) | 3.58852010 |
| 74 | glutathione derivative biosynthetic process (GO:1901687) | 3.58520489 |
| 75 | glutathione derivative metabolic process (GO:1901685) | 3.58520489 |
| 76 | omega-hydroxylase P450 pathway (GO:0097267) | 3.57175344 |
| 77 | reverse cholesterol transport (GO:0043691) | 3.53512268 |
| 78 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.51848987 |
| 79 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.48818930 |
| 80 | primary alcohol metabolic process (GO:0034308) | 3.47701225 |
| 81 | fatty acid catabolic process (GO:0009062) | 3.47412385 |
| 82 | monocarboxylic acid catabolic process (GO:0072329) | 3.47348266 |
| 83 | glutamate metabolic process (GO:0006536) | 3.46916210 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 3.45892583 |
| 85 | phenylpropanoid metabolic process (GO:0009698) | 3.43087603 |
| 86 | triglyceride homeostasis (GO:0070328) | 3.43055178 |
| 87 | acylglycerol homeostasis (GO:0055090) | 3.43055178 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 3.42795701 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 3.42217096 |
| 90 | protein-lipid complex remodeling (GO:0034368) | 3.42217096 |
| 91 | macromolecular complex remodeling (GO:0034367) | 3.42217096 |
| 92 | organic acid catabolic process (GO:0016054) | 3.41937550 |
| 93 | carboxylic acid catabolic process (GO:0046395) | 3.41937550 |
| 94 | drug transport (GO:0015893) | 3.41014085 |
| 95 | regulation of cholesterol metabolic process (GO:0090181) | 3.40279509 |
| 96 | regulation of cholesterol esterification (GO:0010872) | 3.39314859 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.36026031 |
| 98 | coenzyme catabolic process (GO:0009109) | 3.35641677 |
| 99 | phospholipid efflux (GO:0033700) | 3.34809726 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.32929674 |
| 101 | valine metabolic process (GO:0006573) | 3.32914859 |
| 102 | L-ascorbic acid metabolic process (GO:0019852) | 3.32004806 |
| 103 | plasma lipoprotein particle clearance (GO:0034381) | 3.31529166 |
| 104 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.31272210 |
| 105 | phospholipid homeostasis (GO:0055091) | 3.30265790 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 3.30227428 |
| 107 | glutathione biosynthetic process (GO:0006750) | 3.29575565 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.29324163 |
| 109 | indolalkylamine metabolic process (GO:0006586) | 3.29270126 |
| 110 | intestinal absorption (GO:0050892) | 3.27352123 |
| 111 | arginine metabolic process (GO:0006525) | 3.24172965 |
| 112 | axonemal dynein complex assembly (GO:0070286) | 3.20917695 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.15422721 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.15422721 |
| 115 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.12567868 |
| 116 | sulfate transmembrane transport (GO:1902358) | 3.11367644 |
| 117 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.09850223 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.06642260 |
| 119 | oxaloacetate metabolic process (GO:0006107) | 2.95235237 |
| 120 | response to food (GO:0032094) | 2.94654046 |
| 121 | transcytosis (GO:0045056) | 2.94306083 |
| 122 | vitamin transmembrane transport (GO:0035461) | 2.91609288 |
| 123 | renal system process involved in regulation of blood volume (GO:0001977) | 2.91461341 |
| 124 | multicellular organismal water homeostasis (GO:0050891) | 2.90316910 |
| 125 | complement activation, classical pathway (GO:0006958) | 2.88862496 |
| 126 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.85971706 |
| 127 | alkaloid metabolic process (GO:0009820) | 2.84971231 |
| 128 | hemoglobin metabolic process (GO:0020027) | 2.84003802 |
| 129 | positive regulation of fatty acid oxidation (GO:0046321) | 2.82531418 |
| 130 | O-glycan processing (GO:0016266) | 2.81820287 |
| 131 | biotin metabolic process (GO:0006768) | 2.78832460 |
| 132 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.75759343 |
| 133 | complement activation (GO:0006956) | 2.74825993 |
| 134 | quaternary ammonium group transport (GO:0015697) | 2.69055764 |
| 135 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.68902292 |
| 136 | bicarbonate transport (GO:0015701) | 2.68184562 |
| 137 | gas transport (GO:0015669) | 2.65528808 |
| 138 | antibacterial humoral response (GO:0019731) | 2.65283128 |
| 139 | one-carbon metabolic process (GO:0006730) | 2.63505510 |
| 140 | oligosaccharide biosynthetic process (GO:0009312) | 2.62567521 |
| 141 | proline metabolic process (GO:0006560) | 2.61865550 |
| 142 | angiotensin maturation (GO:0002003) | 2.61259062 |
| 143 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.60348463 |
| 144 | carnitine transmembrane transport (GO:1902603) | 2.59499979 |
| 145 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.59246322 |
| 146 | sperm capacitation (GO:0048240) | 2.59172626 |
| 147 | GDP-mannose metabolic process (GO:0019673) | 2.58470120 |
| 148 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.57537525 |
| 149 | creatine metabolic process (GO:0006600) | 2.57310223 |
| 150 | phenol-containing compound catabolic process (GO:0019336) | 2.57053965 |
| 151 | oxygen transport (GO:0015671) | 2.56789528 |
| 152 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.55447686 |
| 153 | protein activation cascade (GO:0072376) | 2.55383055 |
| 154 | amino-acid betaine transport (GO:0015838) | 2.54002872 |
| 155 | carnitine transport (GO:0015879) | 2.54002872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.09593320 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53880609 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.00303183 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.74509144 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.16628476 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.94254641 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.96898866 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.85738506 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.16375828 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.14145233 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.97765537 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.66668620 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.57435324 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.57206043 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.32421574 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.29773726 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26857155 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.19328283 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18096311 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.09707536 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.09494156 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.93740756 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74586211 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.70613452 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66070680 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64657362 |
| 27 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.64437591 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.58188287 |
| 29 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.51529246 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46556071 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45131527 |
| 32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.44480135 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40825697 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38678111 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37501546 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36563826 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36488654 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33000678 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30167816 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28352942 |
| 41 | P68_20966046_ChIP-Seq_HELA_Human | 1.27888468 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26565772 |
| 43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25230654 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24043419 |
| 45 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23569050 |
| 46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22408464 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21224921 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19606948 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18494755 |
| 50 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.17450882 |
| 51 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15469569 |
| 52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13628115 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11976219 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11722378 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10886092 |
| 56 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10191343 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09805337 |
| 58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09770977 |
| 59 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.08511192 |
| 60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07565511 |
| 61 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07452651 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07310790 |
| 63 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07218372 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05485504 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04031237 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02998747 |
| 67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02811664 |
| 68 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02691828 |
| 69 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02442463 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01328408 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01022905 |
| 72 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99544356 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99263907 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99146049 |
| 75 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99117694 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98357944 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98137689 |
| 78 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97522604 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97250416 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97191988 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96960530 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94526478 |
| 83 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94186725 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92876207 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92352338 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92352338 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91890812 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91877613 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91279499 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91123352 |
| 91 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.90481820 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90033126 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88821419 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.88599092 |
| 95 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88166488 |
| 96 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84554459 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84416725 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82766374 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82656280 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81657293 |
| 101 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81577767 |
| 102 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80511877 |
| 103 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79082807 |
| 104 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78883832 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78758654 |
| 106 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78740917 |
| 107 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.77765895 |
| 108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73277167 |
| 109 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71580806 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70407396 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69670333 |
| 112 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.69079597 |
| 113 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.68941615 |
| 114 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.68941615 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68566232 |
| 116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.67944398 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.67255909 |
| 118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.67255909 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.66027115 |
| 120 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.65176996 |
| 121 | ATF3_27146783_Chip-Seq_COLON_Human | 0.64980903 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64901082 |
| 123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62469708 |
| 124 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.61384579 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.60730066 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.60118043 |
| 127 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.59995614 |
| 128 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.57779761 |
| 129 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.56326345 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.56309135 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.53716351 |
| 132 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.53009853 |
| 133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.52905976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.95484999 |
| 2 | MP0005360_urolithiasis | 6.22799369 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 5.57195010 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.23950299 |
| 5 | MP0005365_abnormal_bile_salt | 5.10824385 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.95361618 |
| 7 | MP0005083_abnormal_biliary_tract | 3.19442786 |
| 8 | MP0003252_abnormal_bile_duct | 3.03236653 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.02620656 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.96269706 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.79001469 |
| 12 | MP0004858_abnormal_nervous_system | 2.68432324 |
| 13 | MP0005332_abnormal_amino_acid | 2.55629525 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.50630715 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.40947778 |
| 16 | MP0009840_abnormal_foam_cell | 2.40248822 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.17419749 |
| 18 | MP0004782_abnormal_surfactant_physiolog | 2.09834156 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.86142009 |
| 20 | MP0009643_abnormal_urine_homeostasis | 1.84189752 |
| 21 | MP0003186_abnormal_redox_activity | 1.82567087 |
| 22 | MP0000609_abnormal_liver_physiology | 1.80240007 |
| 23 | MP0000566_synostosis | 1.79382201 |
| 24 | MP0003195_calcinosis | 1.79277646 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.75172173 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.70486818 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.65947595 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52826861 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.45530867 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.43930406 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.43176972 |
| 32 | MP0005636_abnormal_mineral_homeostasis | 1.42773801 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.36079652 |
| 34 | MP0003868_abnormal_feces_composition | 1.33128579 |
| 35 | MP0001764_abnormal_homeostasis | 1.28751588 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.28363631 |
| 37 | MP0002009_preneoplasia | 1.22194127 |
| 38 | MP0009764_decreased_sensitivity_to | 1.20768679 |
| 39 | MP0003866_abnormal_defecation | 1.20589634 |
| 40 | MP0004043_abnormal_pH_regulation | 1.19929517 |
| 41 | MP0001664_abnormal_digestion | 1.18993523 |
| 42 | MP0002249_abnormal_larynx_morphology | 1.13228759 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.12672932 |
| 44 | MP0002132_abnormal_respiratory_system | 1.12553166 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.12315959 |
| 46 | MP0003879_abnormal_hair_cell | 1.10395206 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.07895590 |
| 48 | MP0001849_ear_inflammation | 1.07891879 |
| 49 | MP0001756_abnormal_urination | 1.05974553 |
| 50 | MP0001873_stomach_inflammation | 1.03647588 |
| 51 | MP0001958_emphysema | 1.03508364 |
| 52 | MP0001881_abnormal_mammary_gland | 1.00357431 |
| 53 | MP0003724_increased_susceptibility_to | 0.99387556 |
| 54 | MP0005408_hypopigmentation | 0.99271242 |
| 55 | MP0002136_abnormal_kidney_physiology | 0.99185353 |
| 56 | MP0000598_abnormal_liver_morphology | 0.98037258 |
| 57 | MP0000678_abnormal_parathyroid_gland | 0.97815588 |
| 58 | MP0000477_abnormal_intestine_morphology | 0.96871819 |
| 59 | MP0008995_early_reproductive_senescence | 0.96254011 |
| 60 | MP0004130_abnormal_muscle_cell | 0.96160951 |
| 61 | MP0001765_abnormal_ion_homeostasis | 0.94412446 |
| 62 | MP0002168_other_aberrant_phenotype | 0.92511599 |
| 63 | MP0004947_skin_inflammation | 0.91695042 |
| 64 | MP0002796_impaired_skin_barrier | 0.89455644 |
| 65 | MP0005451_abnormal_body_composition | 0.88579529 |
| 66 | MP0005058_abnormal_lysosome_morphology | 0.87534544 |
| 67 | MP0003123_paternal_imprinting | 0.86492080 |
| 68 | MP0002254_reproductive_system_inflammat | 0.86050747 |
| 69 | MP0008469_abnormal_protein_level | 0.85862600 |
| 70 | MP0009115_abnormal_fat_cell | 0.85121131 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 0.83350574 |
| 72 | MP0000003_abnormal_adipose_tissue | 0.80440668 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 0.80040926 |
| 74 | MP0005670_abnormal_white_adipose | 0.79811699 |
| 75 | MP0003011_delayed_dark_adaptation | 0.79176660 |
| 76 | MP0009763_increased_sensitivity_to | 0.79170355 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.79140968 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.78755371 |
| 79 | MP0001661_extended_life_span | 0.78667880 |
| 80 | MP0005248_abnormal_Harderian_gland | 0.77785182 |
| 81 | MP0005647_abnormal_sex_gland | 0.76880389 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.73836146 |
| 83 | MP0003075_altered_response_to | 0.72853779 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.72590449 |
| 85 | MP0003300_gastrointestinal_ulcer | 0.72063726 |
| 86 | MP0000627_abnormal_mammary_gland | 0.71592902 |
| 87 | MP0008004_abnormal_stomach_pH | 0.70589868 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.69434814 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.69085085 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.68514831 |
| 91 | MP0000490_abnormal_crypts_of | 0.66609613 |
| 92 | MP0002822_catalepsy | 0.66554875 |
| 93 | MP0005166_decreased_susceptibility_to | 0.66454073 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.66314530 |
| 95 | MP0008260_abnormal_autophagy | 0.66289277 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.65343324 |
| 97 | MP0003045_fibrosis | 0.65121141 |
| 98 | MP0005266_abnormal_metabolism | 0.64981024 |
| 99 | MP0004147_increased_porphyrin_level | 0.63590012 |
| 100 | MP0008872_abnormal_physiological_respon | 0.63467955 |
| 101 | MP0005409_darkened_coat_color | 0.63048388 |
| 102 | MP0000604_amyloidosis | 0.62317067 |
| 103 | MP0003959_abnormal_lean_body | 0.62236973 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.61838391 |
| 105 | MP0003690_abnormal_glial_cell | 0.61645076 |
| 106 | MP0000013_abnormal_adipose_tissue | 0.61537696 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.61482411 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.59442936 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.57512408 |
| 110 | MP0005448_abnormal_energy_balance | 0.57085508 |
| 111 | MP0005464_abnormal_platelet_physiology | 0.57047507 |
| 112 | MP0000537_abnormal_urethra_morphology | 0.55863781 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.55113845 |
| 114 | MP0000249_abnormal_blood_vessel | 0.54925130 |
| 115 | MP0001663_abnormal_digestive_system | 0.54504695 |
| 116 | MP0005164_abnormal_response_to | 0.54189128 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.53751551 |
| 118 | MP0005334_abnormal_fat_pad | 0.52756759 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.52716482 |
| 120 | MP0003878_abnormal_ear_physiology | 0.52716482 |
| 121 | MP0002971_abnormal_brown_adipose | 0.51600717 |
| 122 | MP0002098_abnormal_vibrissa_morphology | 0.51328461 |
| 123 | MP0006054_spinal_hemorrhage | 0.51063804 |
| 124 | MP0009053_abnormal_anal_canal | 0.50859551 |
| 125 | MP0002060_abnormal_skin_morphology | 0.50737746 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.50603533 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.49842332 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.48255817 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.47781957 |
| 130 | MP0008873_increased_physiological_sensi | 0.47366565 |
| 131 | MP0002135_abnormal_kidney_morphology | 0.46682862 |
| 132 | MP0009697_abnormal_copulation | 0.45742753 |
| 133 | MP0000467_abnormal_esophagus_morphology | 0.45068703 |
| 134 | MP0002909_abnormal_adrenal_gland | 0.44263116 |
| 135 | MP0000343_altered_response_to | 0.43787598 |
| 136 | MP0009785_altered_susceptibility_to | 0.43654163 |
| 137 | MP0000462_abnormal_digestive_system | 0.43531791 |
| 138 | MP0004185_abnormal_adipocyte_glucose | 0.43407658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.81184148 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.71796027 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.70142867 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.64181259 |
| 5 | Xanthomatosis (HP:0000991) | 4.86135250 |
| 6 | Decreased circulating renin level (HP:0003351) | 4.41772457 |
| 7 | Gout (HP:0001997) | 4.41610981 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.36890895 |
| 9 | Hyperactive renin-angiotensin system (HP:0000841) | 4.34594052 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.33196855 |
| 11 | Hyperammonemia (HP:0001987) | 4.26534720 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08777160 |
| 13 | Hyperglycinuria (HP:0003108) | 4.07973869 |
| 14 | Complement deficiency (HP:0004431) | 4.04693003 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.03721012 |
| 16 | Flat acetabular roof (HP:0003180) | 4.00530750 |
| 17 | Hypochromic microcytic anemia (HP:0004840) | 3.87526623 |
| 18 | Ketosis (HP:0001946) | 3.76042740 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.70382444 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.70382444 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61866701 |
| 22 | Hyperglycinemia (HP:0002154) | 3.57400522 |
| 23 | Joint hemorrhage (HP:0005261) | 3.50213170 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.47542463 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.46661868 |
| 26 | Abnormality of purine metabolism (HP:0004352) | 3.41016801 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.39532167 |
| 28 | Fat malabsorption (HP:0002630) | 3.39463506 |
| 29 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.37604559 |
| 30 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.36826744 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.36235529 |
| 32 | Chronic bronchitis (HP:0004469) | 3.29561767 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.20990310 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.19613388 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.19224068 |
| 36 | Glomerulonephritis (HP:0000099) | 3.14817102 |
| 37 | Epidermoid cyst (HP:0200040) | 3.13705866 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 3.11587043 |
| 39 | Polycythemia (HP:0001901) | 3.11146928 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.10467183 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.10467183 |
| 42 | Vascular calcification (HP:0004934) | 3.07713600 |
| 43 | Abnormality of methionine metabolism (HP:0010901) | 3.03244951 |
| 44 | Ketoacidosis (HP:0001993) | 3.02413765 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.97377464 |
| 46 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.95578532 |
| 47 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.95578532 |
| 48 | Increased purine levels (HP:0004368) | 2.95457402 |
| 49 | Hyperuricemia (HP:0002149) | 2.95457402 |
| 50 | Metabolic acidosis (HP:0001942) | 2.92489472 |
| 51 | Abnormality of complement system (HP:0005339) | 2.90390547 |
| 52 | Alkalosis (HP:0001948) | 2.89004921 |
| 53 | Hyponatremia (HP:0002902) | 2.81119732 |
| 54 | Esophageal varix (HP:0002040) | 2.81064169 |
| 55 | Abnormality of the intrinsic pathway (HP:0010989) | 2.80847575 |
| 56 | Microcytic anemia (HP:0001935) | 2.75995422 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.75638601 |
| 58 | Hyperbilirubinemia (HP:0002904) | 2.74707213 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.74046565 |
| 60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.73476166 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.69441103 |
| 62 | Abnormal cartilage morphology (HP:0002763) | 2.67844957 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.65049286 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.64493375 |
| 65 | Steatorrhea (HP:0002570) | 2.61828282 |
| 66 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.61574045 |
| 67 | Rhinitis (HP:0012384) | 2.61128336 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 2.60526330 |
| 69 | Lethargy (HP:0001254) | 2.54679362 |
| 70 | Abnormality of the nasal mucosa (HP:0000433) | 2.54214868 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.52973975 |
| 72 | Hyperkalemia (HP:0002153) | 2.52853645 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.51225943 |
| 74 | Nephritis (HP:0000123) | 2.50390187 |
| 75 | Renal salt wasting (HP:0000127) | 2.42436527 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.41523374 |
| 77 | Abnormal ciliary motility (HP:0012262) | 2.41036388 |
| 78 | Nasal polyposis (HP:0100582) | 2.39969670 |
| 79 | Spontaneous abortion (HP:0005268) | 2.39557268 |
| 80 | Malnutrition (HP:0004395) | 2.39413797 |
| 81 | Spastic diplegia (HP:0001264) | 2.37684447 |
| 82 | Abdominal distention (HP:0003270) | 2.36043829 |
| 83 | Vomiting (HP:0002013) | 2.34901497 |
| 84 | Sparse lateral eyebrow (HP:0005338) | 2.32575052 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.30049980 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.30049980 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.27919959 |
| 88 | Proximal tubulopathy (HP:0000114) | 2.27594587 |
| 89 | Abnormality of serum amino acid levels (HP:0003112) | 2.27533203 |
| 90 | Hypochromic anemia (HP:0001931) | 2.27171464 |
| 91 | Congenital sensorineural hearing impairment (HP:0008527) | 2.23717060 |
| 92 | Poikilocytosis (HP:0004447) | 2.22257826 |
| 93 | Absent/shortened dynein arms (HP:0200106) | 2.21214241 |
| 94 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.21214241 |
| 95 | Abnormal hemoglobin (HP:0011902) | 2.20923877 |
| 96 | Abnormality of renin-angiotensin system (HP:0000847) | 2.19217954 |
| 97 | Hyperaldosteronism (HP:0000859) | 2.18372386 |
| 98 | Bronchiectasis (HP:0002110) | 2.18000579 |
| 99 | Abnormality of sodium homeostasis (HP:0010931) | 2.17803294 |
| 100 | Toxemia of pregnancy (HP:0100603) | 2.17074462 |
| 101 | Cerebral edema (HP:0002181) | 2.16583050 |
| 102 | Lip pit (HP:0100267) | 2.15262928 |
| 103 | Myopathic facies (HP:0002058) | 2.14819088 |
| 104 | Respiratory distress (HP:0002098) | 2.11727992 |
| 105 | Tachypnea (HP:0002789) | 2.11620341 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 2.11506860 |
| 107 | Myocardial infarction (HP:0001658) | 2.08913309 |
| 108 | Late onset (HP:0003584) | 2.08082661 |
| 109 | Abnormality of the fingertips (HP:0001211) | 2.08069153 |
| 110 | Tubulointerstitial fibrosis (HP:0005576) | 2.07870738 |
| 111 | Visceral angiomatosis (HP:0100761) | 2.05582655 |
| 112 | Hypokalemic alkalosis (HP:0001949) | 2.04260353 |
| 113 | Acanthocytosis (HP:0001927) | 2.03703252 |
| 114 | Irritability (HP:0000737) | 2.02921797 |
| 115 | Metabolic alkalosis (HP:0200114) | 2.01697910 |
| 116 | Abnormal tarsal ossification (HP:0008369) | 2.01603867 |
| 117 | Abnormality of carpal bone ossification (HP:0006257) | 2.00417710 |
| 118 | Adrenal overactivity (HP:0002717) | 1.99666558 |
| 119 | Neonatal onset (HP:0003623) | 1.99550111 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 1.99439180 |
| 121 | Glycosuria (HP:0003076) | 1.98705748 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.98705748 |
| 123 | Pancreatitis (HP:0001733) | 1.98705423 |
| 124 | Pustule (HP:0200039) | 1.97877610 |
| 125 | Diaphragmatic weakness (HP:0009113) | 1.97444749 |
| 126 | Reticulocytosis (HP:0001923) | 1.95961148 |
| 127 | Glomerulosclerosis (HP:0000096) | 1.95255974 |
| 128 | Neonatal hypoglycemia (HP:0001998) | 1.94540926 |
| 129 | Ileus (HP:0002595) | 1.93938241 |
| 130 | Cholelithiasis (HP:0001081) | 1.93012931 |
| 131 | Hypertriglyceridemia (HP:0002155) | 1.91310432 |
| 132 | Thin bony cortex (HP:0002753) | 1.90537360 |
| 133 | Amyloidosis (HP:0011034) | 1.90424355 |
| 134 | Abnormal gallbladder morphology (HP:0012437) | 1.89967328 |
| 135 | Rickets (HP:0002748) | 1.89665744 |
| 136 | Hypotension (HP:0002615) | 1.88930885 |
| 137 | Abnormality of the gallbladder (HP:0005264) | 1.88928708 |
| 138 | Skin nodule (HP:0200036) | 1.87702554 |
| 139 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86534189 |
| 140 | Hemangiomatosis (HP:0007461) | 1.86223879 |
| 141 | Hemorrhage of the eye (HP:0011885) | 1.84018971 |
| 142 | Cholecystitis (HP:0001082) | 1.83813192 |
| 143 | Abnormal gallbladder physiology (HP:0012438) | 1.83813192 |
| 144 | Cerebral palsy (HP:0100021) | 1.83576959 |
| 145 | Renal tubular acidosis (HP:0001947) | 1.81404966 |
| 146 | Growth hormone excess (HP:0000845) | 1.79665157 |
| 147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76144225 |
| 148 | Abnormality of potassium homeostasis (HP:0011042) | 1.75511643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.49690274 |
| 2 | PRKD3 | 4.06572373 |
| 3 | MST1R | 3.96447467 |
| 4 | AKT3 | 3.35933948 |
| 5 | ERN1 | 3.32469296 |
| 6 | TIE1 | 3.09697615 |
| 7 | TAOK3 | 2.97865543 |
| 8 | FGFR4 | 2.63885805 |
| 9 | SIK1 | 2.54563005 |
| 10 | TRIB3 | 2.35998595 |
| 11 | TGFBR2 | 2.31341517 |
| 12 | EPHB2 | 2.21417555 |
| 13 | PKN2 | 2.19306619 |
| 14 | SMG1 | 2.08232101 |
| 15 | EPHA2 | 2.01635994 |
| 16 | FRK | 1.87526162 |
| 17 | PTK6 | 1.84808733 |
| 18 | ICK | 1.84775271 |
| 19 | PIK3CA | 1.84536520 |
| 20 | WNK4 | 1.77814260 |
| 21 | MYLK | 1.76112471 |
| 22 | RIPK1 | 1.75680939 |
| 23 | TNK2 | 1.67090102 |
| 24 | EPHB1 | 1.66110463 |
| 25 | EEF2K | 1.60313181 |
| 26 | MAP3K3 | 1.55870080 |
| 27 | ACVR1B | 1.50904483 |
| 28 | LMTK2 | 1.48755888 |
| 29 | MAPKAPK3 | 1.45046896 |
| 30 | MAP2K2 | 1.44063316 |
| 31 | LRRK2 | 1.43197384 |
| 32 | MAP2K3 | 1.41798647 |
| 33 | PRKD2 | 1.36785975 |
| 34 | EIF2AK1 | 1.35440673 |
| 35 | FLT3 | 1.34113395 |
| 36 | TYK2 | 1.33551839 |
| 37 | MET | 1.33126514 |
| 38 | NEK9 | 1.26318868 |
| 39 | TESK1 | 1.23048148 |
| 40 | MAP3K7 | 1.22988746 |
| 41 | MAP3K2 | 1.21783500 |
| 42 | INSRR | 1.15208326 |
| 43 | MST4 | 1.15049063 |
| 44 | KDR | 1.14623664 |
| 45 | PIK3CG | 1.13151959 |
| 46 | TBK1 | 1.12704840 |
| 47 | FGFR2 | 1.11580695 |
| 48 | MATK | 1.11121743 |
| 49 | DAPK2 | 1.10481818 |
| 50 | PAK4 | 1.09525078 |
| 51 | PTK2 | 1.05067896 |
| 52 | RIPK4 | 1.02970166 |
| 53 | MAPK11 | 1.02520771 |
| 54 | ZAP70 | 0.98936882 |
| 55 | STK38L | 0.96330012 |
| 56 | ERBB2 | 0.96167236 |
| 57 | FER | 0.92314144 |
| 58 | ERBB4 | 0.91992256 |
| 59 | GRK6 | 0.91933187 |
| 60 | PRPF4B | 0.91374015 |
| 61 | LATS1 | 0.90256013 |
| 62 | PDPK1 | 0.89097367 |
| 63 | CSK | 0.88074450 |
| 64 | GRK1 | 0.87656449 |
| 65 | MAP2K1 | 0.86827408 |
| 66 | PRKAA2 | 0.85595760 |
| 67 | RPS6KA2 | 0.85010135 |
| 68 | ABL2 | 0.84893538 |
| 69 | JAK2 | 0.81800390 |
| 70 | TAOK2 | 0.81546543 |
| 71 | TGFBR1 | 0.80754413 |
| 72 | TRPM7 | 0.80581190 |
| 73 | PDK3 | 0.79823407 |
| 74 | PDK4 | 0.79823407 |
| 75 | OXSR1 | 0.77426037 |
| 76 | PRKG2 | 0.77310105 |
| 77 | RPS6KB2 | 0.75547415 |
| 78 | STK10 | 0.75372137 |
| 79 | SGK2 | 0.73263140 |
| 80 | HIPK2 | 0.70743654 |
| 81 | MAP2K6 | 0.68467657 |
| 82 | PINK1 | 0.67088529 |
| 83 | SGK494 | 0.66669594 |
| 84 | NEK6 | 0.66333339 |
| 85 | MAP2K4 | 0.66071656 |
| 86 | CDK6 | 0.65134825 |
| 87 | IKBKE | 0.63681155 |
| 88 | RET | 0.62886602 |
| 89 | GSK3A | 0.62789363 |
| 90 | WNK3 | 0.62557290 |
| 91 | TEC | 0.61966520 |
| 92 | MTOR | 0.60476427 |
| 93 | CAMK1D | 0.60368751 |
| 94 | PDK2 | 0.59939648 |
| 95 | RPS6KL1 | 0.59926815 |
| 96 | RPS6KC1 | 0.59926815 |
| 97 | PRKCI | 0.59815610 |
| 98 | MAP3K11 | 0.59052977 |
| 99 | CDK9 | 0.58943086 |
| 100 | SGK3 | 0.57882518 |
| 101 | MAPK15 | 0.56092027 |
| 102 | PDGFRA | 0.55170469 |
| 103 | STK39 | 0.54691270 |
| 104 | TTN | 0.53085467 |
| 105 | PDGFRB | 0.52630506 |
| 106 | STK24 | 0.51710846 |
| 107 | DDR2 | 0.51436571 |
| 108 | MARK2 | 0.51272504 |
| 109 | JAK1 | 0.51246506 |
| 110 | EPHA3 | 0.50725947 |
| 111 | MAP3K6 | 0.50690369 |
| 112 | STK38 | 0.50534152 |
| 113 | FGFR3 | 0.48471356 |
| 114 | FGR | 0.46989512 |
| 115 | MAP3K1 | 0.46650748 |
| 116 | PRKACG | 0.46277101 |
| 117 | RPS6KA6 | 0.44891258 |
| 118 | MAPK4 | 0.44853856 |
| 119 | MAP3K12 | 0.44784945 |
| 120 | CDC42BPA | 0.44783538 |
| 121 | PRKD1 | 0.44781937 |
| 122 | DYRK1B | 0.44731226 |
| 123 | BRSK2 | 0.44603576 |
| 124 | PDK1 | 0.43037252 |
| 125 | IGF1R | 0.42487419 |
| 126 | TAOK1 | 0.41596159 |
| 127 | EGFR | 0.41279902 |
| 128 | KSR2 | 0.41191959 |
| 129 | DAPK3 | 0.39107548 |
| 130 | IRAK3 | 0.38652163 |
| 131 | PRKCZ | 0.37667091 |
| 132 | PRKAA1 | 0.36756395 |
| 133 | MAPK12 | 0.36628807 |
| 134 | NEK1 | 0.35804109 |
| 135 | ITK | 0.35789700 |
| 136 | MAPKAPK2 | 0.34651765 |
| 137 | SGK223 | 0.34218963 |
| 138 | ILK | 0.34115845 |
| 139 | YES1 | 0.29996329 |
| 140 | BMX | 0.28975797 |
| 141 | GRK5 | 0.28670350 |
| 142 | PAK3 | 0.28634287 |
| 143 | CAMKK1 | 0.27707799 |
| 144 | MAPK7 | 0.26839241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.48802695 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40504749 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.85778300 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.75440645 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.69728759 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.65104561 |
| 7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.62523793 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62469472 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61158285 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57125805 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.52868488 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48313850 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44730995 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40622030 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22450911 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.18915973 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.17624278 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11227975 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.09449782 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.00298716 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.97998840 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94824476 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88131250 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86172802 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85411395 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84317989 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79148464 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77272010 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.71459074 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66146093 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.59674097 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50517809 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50194347 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48074788 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44731881 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.39250233 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.38024121 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31256540 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29439019 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28214054 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27585302 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27361250 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21744666 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21262289 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17475056 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.17432276 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.08836578 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07762736 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05257094 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05159908 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03198958 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02958159 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01411131 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91314892 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83264708 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82046509 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81760539 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79700500 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77338555 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71776417 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67221264 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63293317 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59956102 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59825378 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57961863 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55353920 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.54507250 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52819183 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52193034 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50662745 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50207121 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.49709340 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48748056 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45273736 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45058126 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44486315 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40139292 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.39346791 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35021527 |
| 80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33947201 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31939937 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31373703 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30568776 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30170388 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28595214 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27625901 |
| 87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27479509 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.26672415 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26471798 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25757348 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25737479 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24581178 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21220983 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18044027 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14933263 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14687370 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14259929 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09790338 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08781433 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.07726218 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.07377861 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.06568535 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.05979262 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04242752 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03963596 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03412200 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.00394986 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.00315246 |
| 109 | Pertussis_Homo sapiens_hsa05133 | -0.0809497 |
| 110 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0776117 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | -0.0708037 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0681228 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0640016 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0627154 |
| 115 | Lysosome_Homo sapiens_hsa04142 | -0.0513512 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0412818 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0275218 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0180611 |
| 119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0149629 |

